Damm Oliver, Witte Julian, Wetzka Stefanie, Prosser Christine, Braun Sebastian, Welte Robert, Greiner Wolfgang
Department of Health Economics and Health Care Management, School of Public Health, Bielefeld University, Universitätsstraße 25, 33615, Bielefeld, Germany.
GlaxoSmithKline Germany, Prinzregentenplatz 9, 81675, Munich, Germany.
Int J Public Health. 2016 Sep;61(7):847-60. doi: 10.1007/s00038-016-0842-8. Epub 2016 Aug 4.
Despite the availability of vaccines and the existence of public vaccination recommendations, outbreaks of vaccine-preventable childhood diseases still cause public health debate. The objective of this systematic review was to provide an overview of the current epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany.
We systematically reviewed studies published since 2000. The literature search was conducted using PubMed and EMBASE. Also, we used German notification data to give an up-to-date overview of the epidemiology of the four diseases under consideration.
Thirty-six studies were included in our review. Results suggest that there is still considerable morbidity due to childhood diseases in Germany. Studies providing cost estimates are scarce. Comparative analyses of different data sources (notification data vs. claims data) revealed a potential underestimation of incidence estimates when using notification data. Furthermore, several studies showed regional differences in incidence of some of the diseases under consideration.
Our findings underline the need for improved vaccination and communication strategies targeting all susceptible age and risk groups on a national and local level.
尽管有疫苗可用且存在公共疫苗接种建议,但可通过疫苗预防的儿童疾病暴发仍引发了公共卫生方面的争论。本系统评价的目的是概述德国麻疹、腮腺炎、百日咳和水痘的当前流行病学情况及经济负担。
我们系统回顾了2000年以来发表的研究。使用PubMed和EMBASE进行文献检索。此外,我们利用德国的通报数据对所考虑的四种疾病的流行病学情况给出最新概述。
我们的综述纳入了36项研究。结果表明,德国儿童疾病仍有相当高的发病率。提供成本估计的研究很少。对不同数据源(通报数据与索赔数据)的比较分析显示,使用通报数据时可能会低估发病率估计值。此外,几项研究显示了所考虑的某些疾病发病率的地区差异。
我们的研究结果强调,有必要在国家和地方层面针对所有易感年龄组和风险群体改进疫苗接种和沟通策略。